For those who don’t benefit from modulators, the fight against CF can feel isolating and uncertain. Five members of our community share how they’ve transformed their personal struggles into purpose — ...
While exploring Paradise Island, you might notice glowing rifts indicating tears in space and time. If you jump into one, you ...
Swave Photonics, the true holographic display company, today announced that its Holographic eXtended Reality (HXR) Spatial ...
Zacks Investment Research on MSN
VTYX Stock Skyrockets 156% in a Month: Here's What You Need to Know
Shares of Ventyx Biosciences VTYX have skyrocketed 156% in the past month. The massive surge in the stock price was primarily ...
Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator ...
Vitamin D is vital for health, but too much can be harmful, leading to hypercalcemia. Dr. Eric Berg highlights the Coimbra ...
Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...
- These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal progression in type 2 diabetes ...
Cystic fibrosis (CF) is a genetic disorder affecting around 90,000 people worldwide. It is commonly caused by the ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, ...
Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback